Myelodysplastic/Myeloproliferative Neoplasm

Myelodysplastic/Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

528 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 115
Recruiting: 70
Ph III recruiting: 3
Growth YoY: —
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (77)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06680661	ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis	suspended	Phase 2	20	Leland MethenyOTHER	1	Sep 10, 2026	clinicaltrials
NCT06630221	Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations	suspended	Phase 2	25	Abhay Singh, MD MPHOTHER	1	Jun 5, 2026	clinicaltrials